We previously reported that E‐ to N‐cadherin switching, an expression of EMT, was a strong and independent predictor of disease progression in prostate cancer 9, a finding that is currently sustained in the prolonged follow‐up and expansion of our series. Here, CDH2 is linked to prostate cancer.